misleading statements

PayPal faces class action lawsuit alleging securities fraud after stock plummets 20% on disappointing earnings, withdrawn guidance, and CEO transition.

Plug Power faces securities fraud class action for allegedly misrepresenting hydrogen facility capabilities and DOE funding prospects. Shareholders have until April 3, 2026 to join suit.

Law Offices of Frank R. Cruz files class actions against $AGHI, $FRMI, $VRNS, $ARDT for materially false statements. Lead plaintiff deadlines March 2-9, 2026.

Rosen Law Firm announces March 16, 2026 deadline for investors to join securities class action against Vistagen Therapeutics ($VTGN) over alleged misleading statements regarding fasedienol drug trial.

Mereo BioPharma faces securities class action for allegedly concealing failed Phase 3 trials for setrusumab. Investors have until April 6, 2026 to act.

Agilon Health faces securities class action over alleged 2025 guidance misstatements. Lead plaintiff deadline is March 2, 2026 for investors with losses.

Law firm sues Plug Power for allegedly misrepresenting DOE loan prospects and hydrogen facility viability, claiming investor harm through false statements.

Class action filed against $FRMI alleging materially false statements about Project Matador tenant demand and overstated financial prospects since October 2025 IPO.

Class action lawsuit filed against $UGXY alleging securities fraud related to setrusumab clinical trial data. Investors from August 2023 to December 2025 eligible.

Rosen Law Firm seeks lead plaintiffs for PomDoctor securities class action alleging fraud, insider dumping, and misleading statements. $100K+ loss threshold for investor eligibility.

Rosen Law Firm notifies Inovio investors of securities class action with April 7, 2026 lead plaintiff deadline, citing alleged false statements on manufacturing and regulatory matters.

Rosen Law Firm sues Franklin BSP Realty Trust for allegedly misleading investors about dividend sustainability. Lead plaintiff deadline set for April 27, 2026.

Ramaco Resources faces securities lawsuit alleging false statements about Brook Mine operations. Investors who purchased stock July-October 2025 may join class action litigation.

Rosen Law Firm sues Corcept Therapeutics for allegedly making misleading statements about clinical trial data and FDA approval prospects for its relacorilant drug candidate.

Corcept faces securities lawsuit over misleading relacorilant claims. FDA rejected the drug, triggering 50% stock decline and $3.6B market cap loss.

BellRing Brands faces securities lawsuit alleging executives misrepresented 2025 sales drivers, attributing growth to retail inventory builds rather than consumer demand. Stock fell 33% after retailers reduced excess inventory.

Class action lawsuits filed against Lakeland Industries and Navan Inc. allege misleading disclosures. Lead plaintiff deadline is April 24, 2026.

Ramaco Resources faces class action lawsuit alleging executives made false statements about Brook Mine operations, claiming mining activity had commenced when it hadn't.

REGENXBIO faces securities lawsuit alleging misleading statements about RGX-111 gene therapy. Lead plaintiff deadline extended to April 14, 2026.

NuScale Power faces shareholder lawsuit alleging false statements about ENTRA1 partnership qualifications and undisclosed risks. Stock dropped 12% after revealing $495M payment and $532M quarterly loss.